Kirby McInerney LLP Announces Investigation Against AVITA Medical, Inc. on Behalf of InvestorsGlobeNewsWire • 08/22/25
INVESTOR ALERT: Investigation of AVITA Medical, Inc. (RCEL) Announced by Holzer & Holzer, LLCGlobeNewsWire • 08/22/25
Securities Fraud Investigation Into AVITA Medical, Inc. (RCEL) Announced – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law FirmBusiness Wire • 08/21/25
Securities Fraud Investigation Into AVITA Medical, Inc. (RCEL) Announced – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. CruzBusiness Wire • 08/20/25
AVITA Medical Reports Second Quarter 2025 Financial Results, Updates Full-Year Guidance, and Highlights Continued Clinical InnovationGlobeNewsWire • 08/07/25
AVITA Medical's RECELL Platform Recognized for Surgical Innovation in 2025 MedTech Breakthrough AwardsGlobeNewsWire • 06/04/25
AVITA Medical to Present Breakthrough Clinical Data in Burn and Wound Care at ABA 2025GlobeNewsWire • 04/09/25
AVITA Medical Launches Cohealyx, Supporting Healing and Unlocking New Market OpportunityGlobeNewsWire • 04/03/25
AVITA Medical Announces Exclusive Manufacturing and Distribution Agreements with Stedical ScientificGlobeNewsWire • 03/17/25
Wall Street Analysts Predict a 52.64% Upside in Avita Medical (RCEL): Here's What You Should KnowZacks Investment Research • 02/20/25
AVITA Medical: A Dip Buy As 2025 Looks Bullish With Cohealyx And RECELL GO MiniSeeking Alpha • 01/10/25